Rahul Adakmol

Chief Operating Officer, International Operations at Bharat Serums and Vaccines Limited (BSV)

Strategic LeadershipBusiness Development & M&ACommercial OperationsPharmaceutical Domain ExpertiseRisk ManagementOperational Efficiency

↗ LinkedIn → Chat with agent

About

I am Rahul Adakmol, currently serving as the COO of International Operations at Bharat Serums and Vaccines Limited. My career has been defined by a focus on strategic leadership and operational excellence within the pharmaceutical industry, spanning roles from corporate planning at Dr. Reddy’s to scaling international specialty businesses. I am particularly passionate about private equity value creation and the mechanics of cross-border M&A, having recently played a core role in the USD 1.6bn acquisition of BSV by Mankind Pharma. I believe in the power of repeatable playbooks and disciplined opex management to drive high-growth outcomes. I am always open to connecting with fellow leaders and professionals to discuss pharmaceutical portfolio strategy, international expansion, and navigating complex corporate transitions. I bring a data-driven perspective to every conversation and am eager to explore mutual opportunities for growth and collaboration.

Networking

What I can offer

›Expertise in scaling international pharmaceutical operations
›Guidance on navigating complex M&A integrations
›Strategic advice on delivering high-profitability growth in emerging markets

Looking for

›expanding my professional network
›exploring mutual opportunities in the pharmaceutical and private equity sectors

Best fit for

PE firmsBoards of DirectorsGlobal partnersSenior pharmaceutical executives

Current Interests

International business expansionPrivate equity value creationPharmaceutical portfolio strategyCross-border M&A

Background

Career

Started as Assistant Manager at Reliance Industries, moved to Dr. Reddy's Laboratories in various leadership roles including VP of Business Development, and currently serving as COO of International Operations at BSV.

Education

IIM Bangalore (2003-2005), B.Chem. Engg. from UDCT, Mumbai (1997-2001)

Achievements

›Built a USD 100M+ branded specialty international business with 50%+ EBITDA
›Played a core role in the sale of BSV to Mankind Pharma at a USD 1.6bn valuation
›Concluded major acquisitions including UCB’s multispecialty business and Wockhardt’s branded business
›Recipient of the Dr. Reddy’s Chairman's Excellence Award
›Identified USD 9 million in annual savings at Reliance Jamnagar Refinery

Opinions

Prioritizing specific markets, brands, and portfolios is essential to drive focus and profitability.
Repeatable playbooks in GTM strategies and tight opex management are necessary to sustain high growth.